Stem cell-related markers in primary breast cancers and associated metastatic lesions. - Wikidata - awgldk - TriplyDB

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

http://www.wikidata.org/entity/Q36104759

about

microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers Clinicopathologic characteristics of breast cancer stem cells identified on the basis of aldehyde dehydrogenase 1 expression.Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.Fhit loss-associated initiation and progression of neoplasia in vitro.Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.Cancer stem cells and their implication in breast cancer.Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.Decoding the cancer stem cell hypothesis in glioblastoma.Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo.Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy.Development of suspension cell culture model to mimic circulating tumor cells.Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma.Survival of breast cancer patients according to changes in expression of selected markers between primary tumor and lymph node metastases.Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

P2860

Q33576814-10F65407-481D-4F40-B1DA-57561CF09255 Q33875805-C5D35B09-C999-47C5-A081-F1C1A0411E41 Q34158093-16B68EB3-AE30-44AC-9A8F-AFC87BCAE002 Q34868601-ABA304CA-A0EF-49D3-8036-1B4C88CAE789 Q36170933-99E98509-AD37-494E-B0E8-D991FD3F8F04 Q36190094-21FD83CA-69EE-45BD-8583-2E1FD21C2030 Q36746291-5A9F9CCF-E0B8-44F5-AC47-92D065445207 Q36997687-298EF96A-F6DE-4793-9838-9B325ED283C8 Q37462501-27327A2F-B764-4073-A566-703255CAACE3 Q37513954-FEC1856B-E937-47CF-9B8E-A889BA6DB602 Q38207159-A650F1AB-8937-4BD0-93D3-6E2A21F1AE4C Q38755283-2F2E8F8E-0531-4B9B-9DE7-003C04BD1099 Q42115145-F8873DD0-497F-4657-982A-FB0132A12DAB Q42503675-93D2F9DC-6ADE-40E4-8F75-3E8CE8C9C8CE Q45562323-D2EBCA29-C890-4881-BC07-6C74C082DF88 Q50128323-928EA922-D705-4BDB-B496-65C69924FAFF Q51395620-76967F6C-3309-4FC4-AE0C-60B0E07B1DEA Q53635504-17625106-407C-4BCD-A8A5-4DA65D5BF5AC Q54208413-0409AACC-70E6-44C1-B8B6-3D36BDAA7955 Q55110745-51994F7D-3BEA-45F5-91F5-58D22A3BD911

P2860

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

http://www.wikidata.org/entity/Q36104759

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@ast

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@en

type

label

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@ast

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@en

prefLabel

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@ast

Stem cell-related markers in primary breast cancers and associated metastatic lesions.

@en

P1433

Q36104759-2FFE4EE3-88BB-4DC2-9B03-F22C45823353

P1476

Q36104759-A49C5768-26BA-4857-BFDE-E623FFE28353

P2093

Q36104759-1944608D-E16B-4EE8-87A7-8ABE39F79948

Q36104759-207ACF0E-AEEF-47E5-A2FB-BB996E933672

Q36104759-2D83CBCC-4DBA-4755-97FE-9996CD7DCD1A

Q36104759-354C87E7-AC1A-4DC2-B7BB-E078D46E2A3A

Q36104759-3F20F905-CA4D-408B-9C57-448B5E373B44

Q36104759-4EE85A78-30C5-4C53-A87F-62DAA82ED94A

Q36104759-5339779F-819C-4A93-8173-631B9E626F05

Q36104759-78403D93-BAD0-4F31-A09C-02AEDD0B03A5

Q36104759-7A13D501-2D94-4606-8FC0-427F39F19074

Q36104759-7E50A75C-C277-49A0-8550-25E45DDC5CEF

P2860

Q36104759-29FBD2E2-2226-4804-A3AC-824A9C038584

Q36104759-3543D98F-74CC-47FA-B7BA-1817AAEC1B84

Q36104759-36941C07-2135-46FF-BD1A-73AF07B4794F

Q36104759-4E6179A7-7B51-425B-9EC3-8C8244725D70

Q36104759-4EEFBC3B-5A25-4A85-B349-139501D3E8C6

Q36104759-54315561-4608-42E8-A371-8A6599599F07

Q36104759-5DBF4AFF-BDEC-486E-8085-0D48D6E52BC6

Q36104759-7112F3D1-4A74-48C4-A02E-643262193D2F

Q36104759-734DE5A4-2AA2-4400-B577-003BCC342F49

Q36104759-A7BD1914-0361-4D94-8856-0C4B0CC57271

P2888

Q36104759-B1119594-DF0D-4997-81EB-EF88555FBB51

P304

Q36104759-74D17AFE-0076-44DE-8AA1-081F39DEC1D1

P31

Q36104759-8F49E945-998C-4AD2-A3F6-885B76DCFD64

P356

Q36104759-8872E3C0-37D2-44C0-81EB-E31A0ED87120

P433

Q36104759-F469AC98-1C24-4165-8168-847447D5FCC9

P478

Q36104759-D779C354-47D9-4A13-80FB-39100F425446

P50

Q36104759-FBD508DA-D384-4A19-ADFE-6943721497B2

P577

Q36104759-02D3C051-9D78-448E-B681-ADEF784905CC

P5875

Q36104759-9F4D32B1-CBF5-4072-A85A-A40E2A5B3E65

P698

Q36104759-E5854449-440A-4EB5-ADD7-FD01FB389E5D

P932

Q36104759-5C80E9B0-CF24-4941-8773-D8E0D2C2B4A3

P356

MODPATHOL.2012.37

P1433

Modern Pathology

P1476

Stem cell-related markers in primary breast cancers and associated metastatic lesions

@en

P2093

Charles L Shapiro

http://www.w3.org/2001/XMLSchema#string

Cigdem Himmetoglu Ussakli

http://www.w3.org/2001/XMLSchema#string

Cigdem Irkkan

http://www.w3.org/2001/XMLSchema#string

Dinc Suren

http://www.w3.org/2001/XMLSchema#string

Ebru Sari

http://www.w3.org/2001/XMLSchema#string

Gulnur Guler

http://www.w3.org/2001/XMLSchema#string

Jason Bacher

http://www.w3.org/2001/XMLSchema#string

Kadri Altundag

http://www.w3.org/2001/XMLSchema#string

Kay Huebner

http://www.w3.org/2001/XMLSchema#string

Stefan Costinean

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer

Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.

Snail family regulation and epithelial mesenchymal transitions in breast cancer progression

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases

Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas

P2888

modpathol.2012.37

P304

949-955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2012.37

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221886564

http://www.w3.org/2001/XMLSchema#string

P698

22388757

http://www.w3.org/2001/XMLSchema#string

P932

3400504

http://www.w3.org/2001/XMLSchema#string